Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Summary

This study was intended to assess the safety, efficacy, and response to treatment using the American College of Rheumatology (ACR) criteria of 20% improvement in symptoms (ACR20) and to investigate a potential biomarker profile in adult patients with established rheumatoid arthritis

Timeline

Start

2007-05

Primary completion

2008-09

Completion

2008-09

Drugs

Indications